Cargando…

3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis

BACKGROUND: Late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) is useful for the detection of cardiac amyloidosis (CA), but characteristic LGE patterns do not always occur or they appear late in the disease. Native T1 and extracellular volume (ECV) by T1 mapping may improve diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yumeng, Zhu, Jingfen, Chen, Meng, Wang, Lingjie, Zhu, Mo, Weng, Zhen, Hu, Chunhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372670/ https://www.ncbi.nlm.nih.gov/pubmed/35965812 http://dx.doi.org/10.21037/atm-22-3251

Ejemplares similares

Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis
por: Treibel, Thomas A., et al.
Publicado: (2015)

Comparison of late gadolinium enhancement patterns in different forms of cardiac amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Late Iodine Enhancement and Extracellular Volume Fraction in Cardiac Amyloidosis by Computed Tomography
por: Suzuki, Masataka, et al.
Publicado: (2022)

Prognostic utility of late gadolinium enhancement on cardiac magnetic resonance in cardiac amyloidosis: a meta-analysis
por: Raina, Sameer, et al.
Publicado: (2016)

3.0T Cardiac Magnetic Resonance Quantification of Myocardial Extracellular Volume using different delay time of post-contrast T1 mapping for the Diagnosis of Cardiac Amyloidosis
por: Lin, Lu, et al.
Publicado: (2016)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor
por: Baroni, M., et al.
Publicado: (2017)

Novel quantification of extracellular expansion by cardiac magnetic resonance is a robust marker in diagnosis of cardiac amyloidosis
por: Mongeon, Francois-Pierre, et al.
Publicado: (2011)

Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up
por: Migrino, Raymond Q, et al.
Publicado: (2009)

Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
por: Williams, Lynne K., et al.
Publicado: (2017)

Cardiac phase-resolved late gadolinium enhancement imaging
por: Weingärtner, Sebastian, et al.
Publicado: (2022)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Diagnosis of Cardiac Amyloidosis Using a Radiomics Approach Applied to Late Gadolinium-Enhanced Cardiac Magnetic Resonance Images: A Retrospective, Multicohort, Diagnostic Study
por: Zhou, Xi Yang, et al.
Publicado: (2022)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Extracellular Volume Quantification With Cardiac Late Enhancement Scanning Using Dual-Source Photon-Counting Detector CT
por: Mergen, Victor, et al.
Publicado: (2022)

Quantification of (11)C-PIB kinetics in cardiac amyloidosis
por: Kero, Tanja, et al.
Publicado: (2018)

Cardiac extracellular volume quantified with T1 mapping techniques reflects degree of cardiac and neurological involvement in Hereditary Transthyretin Amyloidosis
por: González-López, Esther, et al.
Publicado: (2015)

Severe Left Ventricular Hypertrophy, Small Pericardial Effusion, and Diffuse Late Gadolinium Enhancement by Cardiac Magnetic Resonance Suspecting Cardiac Amyloidosis: Endomyocardial Biopsy Reveals an Unexpected Diagnosis
por: Hofmann, Nina P., et al.
Publicado: (2016)

Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis
por: Pucci, Angela, et al.
Publicado: (2021)

DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker
por: Scully, Paul R., et al.
Publicado: (2020)

Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?
por: Hayashi, Hidetaka, et al.
Publicado: (2021)

Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis
por: Weng, Zhen, et al.
Publicado: (2016)

Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement
por: Komada, Tomohiro, et al.
Publicado: (2016)

Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study
por: Treiber, Julia, et al.
Publicado: (2023)

Cardiac Amyloidosis
por: Elbdri, Salah, et al.
Publicado: (2021)

Extracellular Volume Fraction Based on Cardiac Magnetic Resonance T1 Mapping: An Effective Way to Evaluate Cardiac Injury Caused by Cardiac Amyloidosis in Patients with Multiple Myeloma
por: Liu, Minghui, et al.
Publicado: (2022)

Right ventricle late gadolinium enhancement in cardiac sarcoidosis: a case series
por: Lydell, Carmen P, et al.
Publicado: (2011)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Modeling of factors affecting late gadolinium enhancement kinetics in MRI of cardiac amyloid
por: Axel, Leon
Publicado: (2023)

Extracellular volume MRI increases the detection of myocardial abnormalities beyond late gadolinium enhancement - initial findings
por: Lundin, Magnus, et al.
Publicado: (2012)

Is signal intensity of late gadolinium enhancement a substitute for extracellular volume mapping in acute myocardial infarction?
por: Garg, Pankaj, et al.
Publicado: (2015)

Extracellular volume fractions are not consistent in gray zones determined by late gadolinium enhancement imaging of myocardial infarction
por: Parikh, Paras, et al.
Publicado: (2016)

Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)
por: Avanesov, Maxim, et al.
Publicado: (2016)

Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping
por: Ioannou, Adam, et al.
Publicado: (2023)

Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy
por: Lavall, Daniel, et al.
Publicado: (2022)

Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping
por: Ioannou, Adam, et al.
Publicado: (2023)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_87tiuq0q9b7cchf3d1t9mt3518